PinnyPeptide

Cardiogen vs Prostamax

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Cardiogen

Bioregulators

Khavinson short peptide bioregulator targeting cardiac muscle and vascular endothelium.

Peptide B

Prostamax

Bioregulators

Khavinson short peptide bioregulator targeting prostate tissue.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Cardiogen effects

  • Reported improvement in myocardial contractility (Russian observational)
  • Possible reduction in age-related cardiac decline
  • Improved exercise tolerance in elderly CAD patients
  • Modulation of cardiac remodeling processes
  • Anti-inflammatory effects in cardiac tissue

Prostamax effects

  • Reported improvement in chronic prostatitis symptoms
  • Possible reduction in BPH-related urinary symptoms
  • Anti-inflammatory effects in prostate tissue
  • Modulation of prostate gene expression
  • Russian observational support for elderly male prostate health

Cardiogen side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation
  • Should not substitute for proven cardiac therapies

Prostamax side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation
  • Not a substitute for proper urological evaluation

Cardiogen dosing ranges

Cardiac function support

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Prostamax dosing ranges

Prostate health support

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Full Cardiogen guide → Full Prostamax guide →

Cardiogen vs Prostamax — common questions

What is the difference between Cardiogen and Prostamax?

Cardiogen: Khavinson short peptide bioregulator targeting cardiac muscle and vascular endothelium. Typical dose 1,000-5,000 mcg. Prostamax: Khavinson short peptide bioregulator targeting prostate tissue. Typical dose 1,000-5,000 mcg. Both fall under the Bioregulators category.

Can you stack Cardiogen and Prostamax?

Stacking Cardiogen with Prostamax is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Cardiogen or Prostamax?

Cardiogen is typically dosed: Once daily (SubQ) or sublingual for Cardiac function support. Prostamax is typically dosed: Once daily (SubQ) or sublingual for Prostate health support.

Are Cardiogen and Prostamax FDA approved?

Cardiogen: Not FDA approved. Prostamax: Not FDA approved.

Related peptide comparisons

bronchogen vs cardiogencardiogen vs cartalaxcardiogen vs cortagencardiogen vs crystagencardiogen vs ovagencardiogen vs pancragen

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free